Oxford BioTherapeutics


Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

Employees

11-50

Links


Org chart

Christian Rohlff
Director & CEO
Collapse
Belinda Cairns
Director Of Histopathology
Ben Thomas
Senior Vp: External Innovation And Operations
Tracy Coltman
EA To CEO
Ken Sayre
Vice President Finance And U S Operations

Board & advisors

Jean-Pierre Bizzari
Non-Executive Director
Jason Gould
Non-Executive Director


Offices